RWM
EBS icon

Ritholtz Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Ritholtz Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Sell
13,197
-52,071
-80% -$436K ﹤0.01% 1274
2026
Q1 		$542K Sell
65,268
-43,652
-40% -$452K 0.01% 761
2025
Q4 		$1.35M Buy
+108,920
New +$1.17M 0.02% 435

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Ritholtz Wealth Management's EBS Position: Q2 2026 in Review

Ritholtz Wealth Management reduced its Emergent Biosolutions (EBS) stake by 80% in Q2 2026, selling an estimated $436K and leaving 13,197 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

Ritholtz Wealth Management first reported a position in EBS in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.35M in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Ritholtz Wealth Management held 13,197 shares of Emergent Biosolutions worth $111K as of Q2 2026.
  • Ritholtz Wealth Management sold 52,071 Emergent Biosolutions shares in Q2 2026, an estimated $436K.
  • Emergent Biosolutions made up ﹤0.01% of Ritholtz Wealth Management's portfolio in Q2 2026, its #1274 holding.
  • Ritholtz Wealth Management first reported a position in Emergent Biosolutions in Q4 2025 and has held it in 3 quarters since.
  • Ritholtz Wealth Management's Emergent Biosolutions position peaked at $1.35M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.